| QOLIE-31 |
Before treatment |
After treatment |
| Mean ± SD (range) |
Mean ± SD (range) |
| Total quality of life |
51.3 ± (29.4-89.8) |
62.6 ± 15.4 (32.586) ** |
| Seizure worry |
55.2 ± (0-100) |
73.4 ±18.2 (18-100)*** |
| Emotional well being |
48.6 ±21.3 (12-100) |
62.1 ± 20.6 (20-89) *** |
| Energy/fatigability |
49.1 ± 21.5(20-95) |
61.6 ± 19.4 (30-95) *** |
| Drug side effects |
41 ± 19.6 (6.6-74) |
45.9 ± 17.6 (17.5-75) * |
| Cognitive effects |
67.9 ± 22.5 (16.6-100) |
76.3 ± 19 (47.2-100) * |
| Social functioning |
53.7 ± 27.4 (14-95) |
71.3 ± 25.5 (19-100) *** |
|
| * p>0.05; **0.05>p>0.01; ***p<0.01 |
| Table 3: Quality of life before and after treatment with nimodipine (ITT analysis). |
